Parmeggiani Andrea, Nissen Poul
Department of Molecular Biology, University of Aarhus, Gustav Wieds Vej 10 C, DK-8000 Aarhus C, Denmark.
FEBS Lett. 2006 Aug 21;580(19):4576-81. doi: 10.1016/j.febslet.2006.07.039. Epub 2006 Jul 24.
Elongation factor Tu (EF-Tu), the carrier of aa-tRNA to the mRNA-programmed ribosome, is the target of four families of antibiotics of unrelated structure, of which the action is supported by two basic mechanisms. Kirromycin and enacyloxin block EF-Tu.GDP on the ribosome; pulvomycin and GE2270 A inhibit the interaction of EF-Tu.GTP with aa-tRNA. The crystallographic analysis has unveiled the structural background of their actions, explaining how antibiotics of unrelated structures and binding modes and sites can employ similar mechanism of action. The selective similarities and differences of their binding sites and the induced EF-Tu conformations make understand how nature can affect the activities of a complex regulatory enzyme by means of low-molecular compounds, and have proposed a suitable approach for drug design.
延伸因子Tu(EF-Tu),即携带氨酰-tRNA至由mRNA编程的核糖体的载体,是四类结构不相关抗生素的作用靶点,其作用由两种基本机制支持。奇霉素和恩拉霉素在核糖体上阻断EF-Tu·GDP;普尔霉素和GE2270 A抑制EF-Tu·GTP与氨酰-tRNA的相互作用。晶体学分析揭示了它们作用的结构背景,解释了结构、结合模式和位点不相关的抗生素如何能采用相似的作用机制。它们结合位点的选择性异同以及诱导的EF-Tu构象有助于理解自然界如何通过低分子化合物影响一种复杂调节酶的活性,并为药物设计提出了合适的方法。